These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38302339)

  • 21. Clinical picture of VITT.
    Chen L; Pavord S
    Semin Hematol; 2022 Apr; 59(2):76-79. PubMed ID: 35512904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection.
    McGonagle D; De Marco G; Bridgewood C
    J Autoimmun; 2021 Jul; 121():102662. PubMed ID: 34051613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term outcome in vaccine-induced immune thrombocytopenia and thrombosis.
    Schönborn L; Seck SE; Thiele T; Kaderali L; Hoffmann T; Hlinka A; Lindhoff-Last E; Völker U; Selleng K; Buoninfante A; Cavaleri M; Greinacher A
    J Thromb Haemost; 2023 Sep; 21(9):2519-2527. PubMed ID: 37394120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fulminant Vaccine-Induced Immune Thrombotic Thrombocytopenia After ChAdOx1 nCoV-19 (AZD1222) Vaccine Administration in a Woman With Obesity: A Case Report.
    Chou YL; Ling WS; Chiou YH
    Acta Neurol Taiwan; 2024 Jun; 33(2)():81-85. PubMed ID: 37848232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Laboratory testing for suspected COVID-19 vaccine-induced (immune) thrombotic thrombocytopenia.
    Favaloro EJ
    Int J Lab Hematol; 2021 Aug; 43(4):559-570. PubMed ID: 34138513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines.
    Long B; Bridwell R; Gottlieb M
    Am J Emerg Med; 2021 Nov; 49():58-61. PubMed ID: 34062319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Laboratory confirmed vaccine-induced immune thrombotic thrombocytopenia: Retrospective analysis of reported cases after vaccination with ChAdOx-1 nCoV-19 in Germany.
    Thiele T; Weisser K; Schönborn L; Funk MB; Weber G; Greinacher A; Keller-Stanislawski B
    Lancet Reg Health Eur; 2022 Jan; 12():100270. PubMed ID: 34901912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombosis with thrombocytopenia syndrome (TTS) following adenovirus vector COVID-19 vaccination in Canada.
    Procter TD; Ogasawara H; Spruin S; Wijayasri S; Abraham N; Blaser C; Hutchings K; Shaw A; Ogunnaike-Cooke S
    Vaccine; 2023 Nov; 41(46):6802-6809. PubMed ID: 37806804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unique features of vaccine-induced immune thrombotic thrombocytopenia; a new anti-platelet factor 4 antibody-mediated disorder.
    Venier LM; Clerici B; Bissola AL; Modi D; Jevtic SD; Radford M; Mahamad S; Nazy I; Arnold DM
    Int J Hematol; 2023 Mar; 117(3):341-348. PubMed ID: 36574172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogenesis of vaccine-induced immune thrombotic thrombocytopenia (VITT).
    Greinacher A; Schönborn L; Siegerist F; Steil L; Palankar R; Handtke S; Reder A; Thiele T; Aurich K; Methling K; Lalk M; Völker U; Endlich N
    Semin Hematol; 2022 Apr; 59(2):97-107. PubMed ID: 35512907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombosis and thrombocytopenia in COVID-19 and after COVID-19 vaccination.
    Iba T; Levy JH
    Trends Cardiovasc Med; 2022 Jul; 32(5):249-256. PubMed ID: 35202800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical care pathway for the evaluation of patients with suspected VITT after ChAdOx1 nCoV-19 vaccination.
    Lee AYY; Al Moosawi M; Peterson EA; McCracken RK; Wong SKW; Nicolson H; Chan V; Smith T; Wong MP; Lee LJ; Griffiths C; Rahal B; Parkin S; Afra K; Ambler K; Chen LYC; Field TS; Lindsay HC; Lavoie M; Li C; Migneault D; Naus M; Piszczek J; Rahmani P; Sreenivasan G; Wan T; Yee A; Zypchen L; Sweet D
    Blood Adv; 2022 Jun; 6(11):3315-3320. PubMed ID: 35201292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NETosis and thrombosis in vaccine-induced immune thrombotic thrombocytopenia.
    Leung HHL; Perdomo J; Ahmadi Z; Zheng SS; Rashid FN; Enjeti A; Ting SB; Chong JJH; Chong BH
    Nat Commun; 2022 Sep; 13(1):5206. PubMed ID: 36064843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccine-induced immune thrombotic thrombocytopenia and patients with cancer.
    Connors JM; Iba T
    Thromb Res; 2022 May; 213 Suppl 1():S77-S83. PubMed ID: 36210565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-PF4 testing for vaccine-induced immune thrombocytopenia and thrombosis and heparin induced thrombocytopenia: Results from a UK National External Quality Assessment Scheme exercise April 2021.
    Reilly-Stitt C; Kitchen S; Jennings I; Horner K; Jones R; Makris M; Walker ID
    J Thromb Haemost; 2021 Sep; 19(9):2263-2267. PubMed ID: 34227230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccine-induced immune thrombotic thrombocytopenia (VITT): Update on diagnosis and management considering different resources.
    Greinacher A; Langer F; Makris M; Pai M; Pavord S; Tran H; Warkentin TE
    J Thromb Haemost; 2022 Jan; 20(1):149-156. PubMed ID: 34693641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology of VITT.
    Pai M
    Semin Hematol; 2022 Apr; 59(2):72-75. PubMed ID: 35512903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT).
    Gabarin N; Arnold DM; Nazy I; Warkentin TE
    Semin Hematol; 2022 Apr; 59(2):89-96. PubMed ID: 35512906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19: Vaccine-induced immune thrombotic thrombocytopenia.
    Danish FI; Rabani AE; Subhani FE; Yasmin S; Koul SS
    Eur J Haematol; 2022 Dec; 109(6):619-632. PubMed ID: 36030503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long VITT: A case report.
    Roberge G; Carrier M
    Thromb Res; 2023 Mar; 223():78-79. PubMed ID: 36709677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.